|
Device Trials Focus of FDA Warning Letters
Last week the FDA posted three separate warning letters to its website citing a sponsor, an investigator and an IRB for a range of violations. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives